ZAMUDIO, Spain--(BUSINESS WIRE)--A study just published in the American Journal of Cardiology describes the use of Progenika´s LIPOchip in a large-scale screening of over 1,200 subjects showing clinical symptoms of Familial Hypercholesterolemia (FH). The study led by Fernando Civeira, PhD, MD from the “Miguel Servet” Hospital in Zaragoza and Miguel Pocoví, PhD from the University of Zaragoza, was perfomed in order to identify patient populations most likely to benefit from genetic testing.
